Empresa Windtree Therapeutics Inc Nasdaq
Acciones
US97382D1054
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 01/02/16 |
Eric Curtis
COO | Chief Operating Officer | 56 | 09/03/20 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Steven Simonson
CTO | Chief Tech/Sci/R&D Officer | 65 | 20/05/14 |
Jamie McAndrew
AUD | Comptroller/Controller/Auditor | 44 | 01/11/13 |
Diane Carman
LAW | General Counsel | 55 | 01/07/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 03/02/21 |
Mark Strobeck
BRD | Director/Board Member | 53 | 22/06/23 |
Leslie Williams
BRD | Director/Board Member | 64 | 03/02/21 |
Craig Fraser
CEO | Chief Executive Officer | 59 | 01/02/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 591 909 | 568 154 ( 95,99 %) | 0 ( 0,000009 %) | 95,99 % |
Información de la empresa
Windtree Therapeutics, Inc.
2600 Kelly Road Suite 100
18976-3622, Warrington
+
http://www.windtreetx.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+67,53 % | 63,85 mil M | |
-0,77 % | 41,83 mil M | |
+45,66 % | 40,65 mil M | |
-10,72 % | 27,12 mil M | |
+13,30 % | 26,52 mil M | |
-22,79 % | 18,69 mil M | |
+4,70 % | 12,73 mil M | |
+24,10 % | 12,11 mil M | |
+27,41 % | 12,07 mil M |